BioStock: Iconovo starts 2023 with negotiations for ICOpre

Iconovo enters the new year with confidence after a rewarding and eventful 2022. During the year, the company moved into new facilities at Ideon Science Park, strengthened the patent portfolio, entered into collaboration with Galenica and initiated a pandemic project together with the Bill & Melinda Gates Foundation. In addition, Iconovo recently entered negotiations with a potential licensing partner for the company’s inhaler ICOpre. CEO Johan Wäborg talks more about the negotiations and possibilities in 2023 in an interview with BioStock.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/01/iconovo-starts-2023-with-negotiations-for-icopre/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se